66 results
8-K
BGLC
BioNexus Gene Lab Corp
1 Apr 24
Departure of Directors or Certain Officers
3:59pm
or state securities, commodities, banking or insurance laws or regulations or any settlement thereof or involvement in mail or wire fraud in connection
DEF 14C
iv8 ycsrpl
29 Feb 24
Information statement
5:16pm
PRE 14C
80uukqdknfj5yu22ov
26 Jan 24
Preliminary information
4:05pm
8-K
EX-1.1
n5971kjylaa1i oq
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
lfgtoe0v 7xxw
21 Jul 23
Prospectus supplement with pricing info
3:37pm